Summary

Report Scope
This goal of this report is to impart in-depth knowledge of the global market for active pharmaceutical ingredients (APIs), in terms of both qualitative and quantitative data, to help readers assess the market landscape, develop business/growth strategies, and analyze their market position. BCC Research estimates market size for 2023 (the base year) and forecasts values for 2024 by the end of 2029. It is important to note that market size reflects the demand for APIs within a region or country rather than the API industry itself.
In this report, the API market is analyzed by manufacturer type, production method, molecule type, region and country. Industry growth trends, drivers, restraints and opportunities in the API market are also discussed in detail. The scope of the study is global.
Report Includes
- 64 data tables and 38 additional tables
- An analysis of the global markets for active pharmaceutical ingredients (APIs)
- Analyses of global market trends, with market revenue data from 2022 to 2023, estimates for 2024, forecast for 2025, and projected CAGRs through 2029
- Estimates of the size and revenue prospects of the global market, along with a market share analysis by origin, drug molecular entity type, manufacturer type, end use and region
- Facts and figures pertaining to the market dynamics, technical advances, API sources, production methods, route of synthesis, regulations, and the impact of macroeconomic variables
- A Porter’s Five Forces model, and global supply chain and PESTLE analyses
- Patent activity featuring issues like patent expiry and its impact on the pharmaceutical market, and details of changes in pharmaceutical drug development
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, ESG score analysis, and the ESG practices of leading companies
- Analysis of the industry structure, including companies’ market shares, strategic alliances, M&A activity and a venture funding outlook
- Company profiles of major players within the industry, including Pfizer Inc., Thermo Fisher Scientific Inc., EuroAPI, Lonza, Siegfried Holding AG, and Divi’s Laboratories Ltd.

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
APIs Defined
Global API Supply Chain
API Production Methods
API Production: Route of Synthesis
Production Methods
Chapter 3 Market Dynamics
Market Dynamics Snapshot
Market Drivers
Resilient Pharmaceutical Demand
Increase in Adoption of Generics
Shift to More Complex Chemical Entities
Growth in the Biologics Market
Advances in API Manufacturing
Government Support
Market Restraints
Strict Regulations and Compliance Requirements
Pricing Pressure in the Generic API Industry
Shortage of Skilled Professionals
Market Trends
Increasing Demand for Complex APIs
Regional Diversification and Supply Chain Resilience
Continuous Flow Manufacturing
Expansion of Single-Use Technologies
Growing Sustainability Practices in API Manufacturing
Increased Outsourcing and CDMO Partnerships
Chapter 4 Emerging Technologies and Developments
Biocatalysis for Complex Synthetic API Manufacturing
Integration of AI and ML
Flexible Manufacturing
Chapter 5 Market Segmentation Analysis
Segmentation Breakdown
API Market, by Manufacturer Type
Captive and Contract Manufacturing Market
Merchant Market
API Market, by Production Method
Chemical Synthesis
Biotech
API Market, by Molecule Type
Small-Molecule APIs
Large Molecule
Geographic Breakdown
API Market, by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 6 Competitive Intelligence
Supplier Landscape
Captive Manufacturers
Contract Manufacturers
Merchant Manufacturers
Generic API Market Landscape
Innovative API Market Landscape
Porter’s Five Forces Analysis
Chapter 7 Appendix
Methodology
Sources
Abbreviations
Company Profiles
AUROBINDO PHARMA
DIVI’S LABORATORIES LTD.
EUROAPI
EVONIK INDUSTRIES AG
LONZA
PFIZER INC.
SIEGFRIED HOLDING AG
TEVA PHARMACEUTICAL INDUSTRIES LTD.
THERMO FISHER SCIENTIFIC INC.
WUXI APPTEC